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Oxidative protein folding is confined to the bacterial periplasm, endoplasmic
reticulum and the mitochondrial intermembrane space. Maintaining a redox
balance requires the presence of reductive pathways. The major thiol-reducing
pathways engage the thioredoxin and the glutaredoxin systems which are
involved in removal of oxidants, protein proofreading and folding. Alterations
in redox balance likely affect the flux of these redox pathways and are
related to ageing and diseases such as neurodegenerative disorders and can-
cer. Here, we first review the well-studied oxidative and reductive processes in
the bacterial periplasm and the endoplasmic reticulum, and then discuss the
less understood process in the mitochondrial intermembrane space, highlight-
ing its importance for the proper function of the cell.
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The reductive and oxidative (redox) environment of
the cell is determined by all the oxidative and reductive
reactions that take place in the different cell compart-
ments. Among those reactions, the balance between the
production and removal of both reactive oxygen spe-
cies (ROS) and reactive nitrogen species (RNS) is criti-
cal [1,2]. ROS and RNS are products of normal cell
metabolism. At elevated levels, they lead to the forma-
tion of highly reactive damaging species, while at nor-
mal levels, they are involved in beneficial cell signalling
and metabolism [3–5]. The maintenance of this balance
is important because it directly influences the environ-
ment in which critical cellular processes take place,
such as the activation of transcription factors, protein
proofreading and protein biogenesis [6–9]. The latter is
of particular interest for mitochondria, as 99% of all
mitochondrial proteins are synthesised in the cytosol.
Thus, these proteins need to be imported into mito-
chondria by highly regulated processes that involve sev-
eral pathways. The main pathways for mitochondrial
protein import are the presequence pathway for pro-
teins targeted to the mitochondrial matrix, and the car-
rier pathway for inner membrane polytopic proteins.
Most of the mitochondrial protein import pathways
require external energy either in the form of ATP
hydrolysis or the presence of the inner membrane elec-
trochemical potential. By contrast, the oxidative folding
pathway for intermembrane space (IMS) proteins oper-
ates without an external energy source and is indepen-
dent of the inner membrane potential. The mechanistic
details of the major energy-requiring import pathways
have been reviewed extensively elsewhere [10–12].
Oxidative protein folding is the process by which a
protein acquires native disulphide bonds and its native
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conformation. This process of structural disulphide
bond insertion takes place not only in the mitochon-
drial IMS but also in the bacterial periplasm and the
endoplasmic reticulum (ER). The machineries in
charge of this oxidative folding have been extensively
studied in the three compartments. As for the reduc-
tive processes, which are necessary for maintaining a
redox balance, the periplasm and the ER possess
reducing mechanisms which serve primarily for disul-
phide isomerisation [13,14]. Unlike those compart-
ments, there is no reducing pathway described so far
for the IMS. However, cytosolic components of the
main disulphide reduction systems, i.e. the thioredoxin
and the glutaredoxin systems, have recently been
shown to localise also into the IMS [15,16] raising
interesting questions about the feasibility and opera-
tion of a reductive pathway in the IMS. In this review,
we discuss primarily the oxidative and reductive pro-
cesses in the IMS and compare them to those operat-
ing in the bacterial periplasm and the ER.
Additionally, we evaluate the importance on redox
homeostasis and putative modus operandi of these
newly identified members of reducing machineries in
the IMS.
Oxidative folding
Oxidative protein folding is a process responsible for the
insertion of disulphide bonds within proteins that allows
them to acquire and/or stabilise their native three-
dimensional structure. It is well established that this
process takes place in three different compartments, i.e.
the periplasm in bacteria, and the endoplasmic reticu-
lum (ER) and the mitochondrial intermembrane space
(IMS) in eukaryotic cells (Fig. 1). In the next section,
the oxidative folding pathways in the bacterial peri-
plasm and the ER will be described as a basis to com-
pare them with the IMS pathway.
Gram-negative bacteria and ER
Before an oxidative folding pathway was discovered in
the mitochondrial IMS, it was believed that oxidative
folding occurred only in the bacterial periplasm and
the ER of eukaryotic cells. In the Gram-negative bac-
terial periplasm, oxidative folding is driven by two
proteins: the periplasmic thiol-disulphide oxidoreduc-
tase DsbA (Dsb for disulphide bond) and the inner
membrane protein DsbB. DsbA is a 21 kDa protein
member of the thioredoxin family and is one of the
most oxidising proteins known so far [17,18]. It con-
tains an active CX2C motif placed in a thioredoxin
domain that forms a mixed disulphide with the
substrate protein which is then released after the for-
mation of an internal disulphide [19,20]. The resulting
reduced DsbA is reoxidised by DsbB [21,22], which
transfers e to quinone and subsequently become oxi-
dised again. Finally, these e are transferred to oxygen
[23,24]. Alternatively, under anaerobic conditions, the
e cascade runs from DsbB onto menaquinone and
then to fumarate [23–25].
The ER is responsible for disulphide formation in a
much wider set of proteins than the periplasm or the
IMS, including cell surface and secreted proteins such
as antibodies. In this compartment, cysteine oxidation
is driven by members of the protein disulphide iso-
merase (PDI) family and by the oxidase Ero1 (ER oxi-
doreductase 1). PDIs have at least one thioredoxin-like
domain. The main PDI in the ER has four thioredoxin
domains, two of which are active CX2C domains that
can accept e from the nascent reduced protein
[26,27]. Then, the PDI-reduced cysteines are oxidised
by the flavin-adenine-dinucleotide (FAD)-linked sulf-
hydryl oxidase, Ero1. The catalytic domains of Ero1
internally shuttle the e onto FAD and this in turn to
molecular oxygen, leading to the production of H2O2
[28–32].
The mitochondrial IMS
In mitochondria, import of IMS proteins plays a vital
role for the physiology of the cell as they are part of
the respiratory chain and are involved in apoptosis,
lipid homeostasis and the transport of metabolites,
metal ions and haem. There are two main import
mechanisms for IMS proteins. One is responsible for
the import of proteins containing a mitochondrial tar-
geting presequence followed by a hydrophobic sorting
domain. The presequence targets the protein to the
translocator of the inner membrane (TIM) 23 complex
where it is cleaved off by the matrix mitochondrial
peptidase (MMP). The hydrophobic sorting domain
functions as a stop-transfer signal that arrests further
translocation into the matrix. A second cleavage just
after the stop-transfer signal takes place in the IMS by
the intermembrane space protease IMP that releases
the mature protein into this compartment [33]. In a
separate pathway, IMS proteins that acquire disul-
phide bonds are imported by the mitochondrial IMS
import and assembly (MIA) pathway. The MIA path-
way is responsible for the import of most proteins
residing in the IMS. The two core components of the
MIA pathway are the oxidoreductase Mia40 and the
sulfhydryl oxidase Erv1 (essential for respiration and
vegetative growth 1) [7,34,35]. Mia40 is widely con-
served among species. It shares with its homologues a
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characteristic domain about 60 amino acids in length
that contains six cysteine residues organised as one
CPC (cysteine–proline–cysteine) and two CX9C motifs
[35,36]. The CX9C motifs stabilise the core of the pro-
tein and form a hydrophobic cleft that serves to bind
and hold substrates, whereas the active CPC motif is
the acceptor of e shuttled from the incoming protein
[7,34,35,37]. In the same way as the periplasm and ER
oxidative pathways, Mia40 is recycled back to an oxi-
dised state by a sulfhydryl oxidase after it oxidises its
substrates. Like its ER counterpart, Erv1 (ALR in
humans) is a FAD-coupled sulfhydryl oxidase that
accepts e from Mia40 and transfers them via FAD
and cytochrome c to molecular oxygen or an unknown
acceptor under aerobic or anaerobic conditions respec-
tively [38–40]. The capacity of the Flavin moiety to
assist both two- and one-electron transfer reactions
seems to be critical for the operation of the oxidative
folding pathways in the different compartments.
Although Mia40 and Erv1 are the key proteins (en-
coded by essential genes) for the oxidative folding
pathway in the IMS, another nonessential factor that
has an auxiliary role is Hot13. This protein is a
cysteine-rich protein (containing 10 cysteines) and has
been proposed to facilitate Mia40 reoxidation by keep-
ing Mia40 in a Zn-free state thus allowing an easier
interaction of Mia40 with Erv1 [41,42].
The classical substrates of the MIA pathway possess
either CX3C or CX9C twin motifs. MIA substrates
have an intermembrane space targeting (ITS) signal
(also known as mitochondria IMS-sorting signal,
MISS) in addition to the twin cysteine motifs and need
to be in a reduced state to cross the translocator of
the outer membrane (TOM) channel formed by
Tom40 to be imported into mitochondria [43,44]. The
proteins of the small TIMs family and members of the
COX family are examples of CX3C and CX9C classical
MIA substrates. The small Tims are proteins that form
two complexes, the essential Tim10–Tim9 complex and
the Tim8–Tim13 complex, to deliver hydrophobic pro-
teins to the TIM22 complex for insertion into the IM
[10,45]. Their importance for human cells was corrobo-
rated by the finding that mutations of the Tim8
human homologue, the deafness dystonia protein
(DDP), are associated with a neurodegenerative disor-
der, the Mohr-Tranebjaerg syndrome [46]. COX family
Fig. 1. The three main protein import
pathways into mitochondria. (A) The MIA
pathway precursors cross the OM
membrane via the TOM channel in a
reduced state. Once in the IMS, they
interact with Mia40 which serves as
receptor and oxidoreductase and promotes
the insertion of disulphide bonds into the
proteins. (B) The presequence pathway
precursors are translocated across the
TOM channel to the TIM23 complex. They
contain a positively charged presequence
that helps them cross the IM in a
membrane potential (DΨ)-dependent
manner. These proteins are then either
fully translocated to the matrix or
transferred to the IM and the presequence
is cleaved off. (C) The carrier pathway
precursors are first delivered to the Tom70
receptor by cytosolic chaperones. In the
IMS, the small Tim proteins help them to
interact with the TIM22 complex for their
insertion into the IM.
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members are involved with the assembly of cyto-
chrome c, an essential component of the respiratory
chain. However, other MIA substrates with different
cysteine patterns have also been identified. Examples
are the copper chaperone for superoxide dismutase
(Ccs) 1 [47], the Fe-S cluster protein Dre2 [48] and the
inner membrane protease Atp23 [49]. The identifica-
tion of these proteins leads to the conclusion that
Mia40 has a wider role in protein import, not only as
an oxidative molecule but also as a receptor [37,50].
Mia40 itself is not a conventional substrate of Mia40
and in fact its import has been found to occur in three
stages. First, it is imported and inserted in the inner
membrane by the TIM23 complex, then interaction
with the endogenous Mia40 helps the core to fold, and
finally the CPC motif is oxidised by an interaction
with Erv1 [51].
Although the e cascade is similar in all three oxida-
tive folding systems in bacteria the ER and the IMS,
the MIA machinery has different mechanistic proper-
ties. Furthermore, the key players Mia40 and Erv1 do
not show homology to their periplasm and ER coun-
terparts. This is shown by the short-term intermediates
formed between the substrates and DsbA or PDI as
compared to the stable intermediates with Mia40.
Another important difference between the three sys-
tems relies on the environment where they take place
as the IMS is more reducing than the periplasm or the
ER. That might explain the reason for more stable
intermediates formed by Mia40.
Among those newly identified redox players in the
IMS, the thiol peroxidase Gpx3 (also called Hyr1 or
Orp1) is of great relevance. Gpx3 is member of the
glutathione peroxidase protein family which acts as a
sensor for H2O2. Gpx3 has a critical role in the activa-
tion of the H2O2 response in the cytosol. Upon H2O2
treatment, Gpx3 becomes oxidised and forms a mixed
intermolecular disulphide with the transcription factor
Yap1. Subsequently, Yap1 becomes activated through
formation of and intramolecular disulphide and trans-
fer to the nucleus. In this mechanism, Gpx3 functions
as a sensor and transducer for the hydroperoxide
response [52]. Recently, it was published that an
IMS-localised Gpx3 form containing an 18-amino acid
N-terminal extension plays an important role in
mitochondria. Cells lacking Gpx3 have defects in
morphology and protein import as well as lower inner
membrane potential [53].
Reducing mechanisms
In the three compartments where oxidative folding
pathways take place, reducing reactions are key for
maintaining the homeostasis between oxidative and
reductive flows, and also for the proper functioning of
these pathways. In the next paragraphs, we will discuss
first the disulphide isomerase machineries that have
evolved in the periplasm and the ER, and then the
requirement for reducing pathways in the IMS for
optimal function of the MIA pathway.
Isomerisation and reductive pathways
in the periplasm and the ER
Thiol oxidation to form disulphide bonds between cys-
teine residues in a denatured state of a protein is a
process prone to error that can be harmful to the cell
because of protein misfolding. To prevent this, the
bacterial periplasm and the ER possess oxidoreduc-
tases that can overcome this problem as they maintain
their active sites in a thiol-reduced state that can
cleave non-native disulphides thereby allowing refor-
mation of the correct ones. Despite differences in the
pathways between the two compartments, they both
share the reduced form of the cofactor nicotinamide-
adenine-dinucleotide phosphate (NADPH) as their pri-
mary e donor (Fig. 2).
In the bacterial periplasm, the oxidoreductases
DsbC and DsbD are responsible for the isomerisation
of non-native disulphides. DsbC is a 23 kDa homod-
imer with both isomerase and chaperone activity [54].
The isomerisation and thus reduction of aberrant
disulphides were shown directly by the accumulation
of misfolded proteins in DsbC mutants and the com-
plementation by the addition of the reductive com-
pound dithiolthreitol (DTT) [13]. The DsbC
thioredoxin domain is kept reduced by the membrane
protein DsbD. DsbD is embedded in the inner mem-
brane of Escherichia coli with two periplasmic-exposed
domains that transfer e from NADPH via thiore-
doxin (Trx) not only to DsbD but also to DsbG as
well [55,56]. Even though both the oxidative and
reducing mechanisms take place in the same compart-
ment, they are kept kinetically separated to prevent
nonfunctional disulphide redox reactions to happen
[57].
In the ER, disulphide bond reshuffling is driven by
members of the PDI family. The reduction of PDI is
mediated by either the interaction with the cysteine
residues of newly synthesised polypepetides in the ER
lumen or the interaction with reduced glutathione
(GSH), which is believed to be transported from the
cytosol [31]. In the cytosol, GSH is kept reduced by a
NADPH-dependent protein, the glutathione reductase
(Glr). This is shown by the fact that the reduction of
ERp57, a PDI family member, is prevented by Glr
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inhibition [58]. In contrast to the bacterial periplasm,
the oxidative and reductive mechanisms are both per-
formed by PDIs, whose redox state is partially oxidised.
The oxidised/reduced ratio of the PDIs dictates its flux
towards oxidising or reducing purposes. When this oxi-
dised/reduced ratio is high, disulphide transfer from
Ero1 to PDIs is prevented by the formation of inter-
molecular disulphides within Ero1. When the ratio is
low, Ero1 can perform its oxidising function towards
PDI [59]. Taken together, the periplasm and ER redox
machineries, both in their oxidising and reducing state,
are key to highly regulated processes that are vital for
the cell/organism fate. Furthermore, they have devel-
oped different mechanisms to keep them properly work-
ing while sharing the same localisation.
The thioredoxin fold is a characteristic motif shared
by many proteins involved in thiol-redox state modifi-
cation. Those proteins are Dsb proteins, PDI, glutare-
doxins and thioredoxins. Its basic structure consists of
three a-helices surrounding four b-sheets and the
active CX2C motif. As members of this protein family
have different (sometimes opposite) roles, fine modifi-
cations (particularly these affecting their redox state)
determine their function [60]. The different redox
properties of these proteins are determined by the type
of amino acids between the cysteine couple in the cat-
alytic site, as well as a loop containing a cis-proline
[61].
The glutaredoxin system is composed of glutaredox-
ins (grx), GSH and GSH reductases. Glutathione is a
Fig. 2. Redox processes in the bacterial
periplasm, endoplasmic reticulum and
mitochondrial intermembrane space. (A)
Redox processes taking place in the
bacterial periplasm. Oxidation of proteins
by DsbA, which is in turn oxidised by the
membrane protein DsbB (left). Electron
flux from the cytosolic Trx system onto
DsbD, then to DsbC and finally to the
protein (right). (B) Redox processes in the
ER. Protein oxidation by PDI and reduced
PDI recycling by e transfer onto Ero1
(left). Protein reduction/isomerisation
pathway by PDI reduced by either GSH or
NADPH (right). (C) Redox processes in the
IMS. Protein import mediated by the
Mia40 oxidation of protein precursors.
Mia40 is kept in an oxidised state by Erv1,
or alternatively by Gpx3. This process may
be facilitated by Hot13 which is proposed
to keep Mia40 in its reduced state ((left).
The Trx and Grx systems were recently
localised in the IMS. It is likely that these
reductive systems play a role in Mia40
reduction to keep the oxidised/reduced
overall state of Mia40 necessary for its
import function and also that they play a
role in protein isomerisation (right).
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c-L-glutamyl-L-cysteinyl-glycine tripeptide that plays a
critical role in redox reactions and is considered as the
major nonprotein thiol-reducing agent. GSH is
involved in proteins thiol-reduction by recycling grx
back to a reductive state as well as in redox cell sig-
nalling by the modification of cysteines through a pro-
cess called glutathionylation [62]. While GSH keeps
grx active (reduced), these proteins are in charge of the
reduction of both protein disulphides and protein–
GSH mixed disulphides. Grx proteins are a group of
widely conserved oxidoreductases of 10–15 kDa with
thioredoxin fold-like domains. They can be classified
into two categories based on their active site: monoth-
iol (CX2S) and dithiol (CX2C). Together with their e

donor role, they are also involved in the regulation of
cellular oxidative stress response. These proteins are
involved in several cellular processes such as transcrip-
tion, cellular differentiation, apoptosis and Fe-S cluster
coordination, and some human isoforms have been
found to be overexpressed in cancer [63–67]. In the
same way as the oxidoreductases within the periplasm,
the ER and the IMS, grx needs to be recycled back to
its active reduced state after intramolecular disulphide
formation. As mentioned before, GSH is responsible
for the reduction of grx disulphide. The resulting glu-
tathione oxidised form (GSSG) is then reduced by the
NADPH-fuelled protein, glutathione reductase.
The thioredoxin system is present in all organisms
and comprises the highly conserved trx protein, trx
reductase (trxR) and NADPH. The trx system works
in a similar way as the grx system, where trx transfers
e onto the substrate through thiol-disulphide
exchange reactions and is critical for maintaining the
redox balance of the cell. Those e follows a cascade
from NADPH to trxR and subsequently to trx. This
system is involved in a wide range of pathways. It is
the donor of reducing equivalents for the peptide
methionine sulfoxide reductase, whose reductase activ-
ity upon methionine reverses the inactivation of several
proteins [68]. Additionally, trx has shown inhibitory
activity on the tumour necrosis factor (TNF) a-
induced activation of the apoptosis signal-regulating
kinase (ASK) 1, which has been related to several dis-
eases such as cancer and neurodegenerative disorders
[69]. Other critical processes such as cell growth, tran-
scription, apoptosis and DNA synthesis among other
functions nonrelated to its redox capacity have been
reported [70,71]. Trx is the defining member of the
thioredoxin protein family. It was first identified as e
donor for ribonucleotide reductase in E. coli [72].
Alike grx, its reducing activity relies on the cysteine
pair of its catalytic CX2C domain. TrxR is a flavopro-
tein that catalyses the reduction of trx. There are two
forms of TrxR, a 35 kDa protein in prokaryotes and a
50 kDa in higher eukaryotes [73], which are struc-
turally different with the active site located in the
FAD-binding domain in the eukaryotic form or in the
NADPH-binding domain in the prokaryotic one
[74,75] (Fig. 3).
The IMS: shared cytosolic-reducing
pathways
Unlike the bacterial periplasm and the ER, there are
no reducing pathways described so far for the IMS.
Nevertheless, the importance of the presence of reduc-
ing systems is overriding for the redox homeostasis to
be kept so it is plausible that the IMS possess such
reductive systems. In fact, proteins from the two main
Fig. 3. The two main thiol-reductive systems. Both the thioredoxin
and the glutaredoxin system use the NADPH produced by the
pentose phosphate pathway enzyme G6PD as their final electron
donor. (A) The thioredoxin system electron flux starts from NADPH
which reduces the thioredoxin reductase, which then reduces the
thioredoxin protein. Finally, the thioredoxin protein transfers this e
to its substrates. (B) The glutaredoxin system follows a similar e
flux with an extra step involving glutathione reductase e transfer
onto glutathione, and subsequently, from glutathione onto
glutaredoxin and then to glutaredoxin substrates.
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thiol-reducing families, the thioredoxin and glutare-
doxin systems that are mostly localised in the cytosol,
were recently found to be present in the IMS of the
yeast Saccharomyces cerevisiae using high-resolution
mass spectrometry and biochemical analysis [15,16].
As shown in the other cellular subcompartments where
oxidative folding takes place, the redox homeostasis
has a critical role as the oxidative pathways need the
complementation of reducing pathways in order to
work properly and keep the cell well-being. The influ-
ence on the reducing pathways into mitochondrial
IMS starts with the fact that protein precursors need
to be in a reduced state in order to cross the OM. This
latter was shown by the facilitated import of small
Tims precursors into mitochondria after treatment
with purified Trx system [76]. Although this external
influence is important, the compartmentalised redox
balance of the IMS is the actual key player. Although
there is no reducing mechanism in the IMS described
so far, the recent identification of several redox-related
proteins with dual cytosolic and IMS localisation has
been reported in several studies. Mechanisms for dual
localisation of some mitochondrial proteins have been
reviewed elsewhere [77]. Proteins belonging to the
thioredoxin family and the peroxiredoxin family might
have redox roles in the IMS [78].
Furthermore, other studies have shown that the
GSH redox potential of the IMS and the cytosol are
linked and that this has an impact on the redox state
of Mia40 [79]. Additionally, the presence of glutare-
doxins within the IMS was demonstrated raising the
possibility that these proteins may be linked to the
oxidative folding process in the IMS. This could be
achieved by ensuring the presence of an appropriate
mixed oxidised/reduced Mia40 population balance,
which is necessary for the proper function of Mia40
[16]. Of particular importance is also the reported
presence of Trx1 and TrR1 in the IMS proteome.
Although the exact function of this system in the IMS
is currently unknown, the matrix-located thioredoxin
system (Trx3 and Trr2 in S. cerevisiae) was shown to
modulate the redox state of the mitochondrial matrix
protein cyclophilin D, a protein involved in the regula-
tion of the mitochondrial permeability transition pore
[80].
Despite the identification of reducing small mole-
cules and proteins within the IMS, and the hints given
for their putative mechanistic and regulatory role in
the interplay with oxidative folding, no clear pathway
has been yet described in this cellular subcompartment.
Given the intriguing localisation of these components
in the IMS and the similarities between the IMS and
both the bacterial periplasm and the ER, it is likely
that complete reducing machineries operate in the IMS
compartment. These reducing machineries might play
important roles within the mitochondrial IMS to keep
the redox balance necessary for the proper function of
the oxidative import pathways. The relative GSH equi-
librium between the cytosol and the IMS and the
Mia40 redox state regulation by Grx give some initial
insight on the roles these systems can perform as the
Trx and Grx systems can compensate each other when
one of them is defective. Another key issue to clarify
will be the link of the IMS reducing systems to the
overall cellular metabolic state, given that the main
NADPH source resides outside the IMS (in the cyto-
sol) in the form of the glucose-6-phosphate dehydroge-
nase (G6PD), the rate limiting enzyme of the pentose
phosphate pathway. Indeed, unpublished data from
our group show import defects in mitochondria from
yeast cells lacking G6PD. The identification and char-
acterisation of the Trx and Grx pathways as well as
the impact of cytosolic redox and metabolic changes
on them will be important to fully comprehend the
links among the mechanism of oxidative folding, pro-
tein homeostasis and redox signalling in the mitochon-
dria intermembrane space.
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